CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid Leukemia | ACS Applied Materials & Interfaces
![Molecular methods for measurable residual disease in acute myeloid leukemia: where are we and where are we going? | SpringerLink Molecular methods for measurable residual disease in acute myeloid leukemia: where are we and where are we going? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12308-020-00440-6/MediaObjects/12308_2020_440_Fig1_HTML.png)
Molecular methods for measurable residual disease in acute myeloid leukemia: where are we and where are we going? | SpringerLink
![Interplay between protein acetylation and ubiquitination controls MCL1 protein stability - ScienceDirect Interplay between protein acetylation and ubiquitination controls MCL1 protein stability - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721014674-fx1.jpg)
Interplay between protein acetylation and ubiquitination controls MCL1 protein stability - ScienceDirect
![Cancers | Free Full-Text | Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia | HTML Cancers | Free Full-Text | Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia | HTML](https://www.mdpi.com/cancers/cancers-13-06181/article_deploy/html/images/cancers-13-06181-g004-550.jpg)
Cancers | Free Full-Text | Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia | HTML
![Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy Caused by Lamin A/C Gene Mutation | Science Translational Medicine Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy Caused by Lamin A/C Gene Mutation | Science Translational Medicine](https://www.science.org/cms/asset/6b1d9352-0fe1-4d85-bf79-a816f0d1ef9e/4-144ra102-f1.gif)
Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy Caused by Lamin A/C Gene Mutation | Science Translational Medicine
![Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms | Leukemia Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fleu.2010.32/MediaObjects/41375_2010_Article_BFleu201032_Fig1_HTML.jpg)
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms | Leukemia
![Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia | Science Translational Medicine Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia | Science Translational Medicine](https://www.science.org/cms/asset/2d6371d4-9db0-4789-b59e-6df38c3af2a6/aaz0463-f1.gif)
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia | Science Translational Medicine
![Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors | Leukemia Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fleu.2013.202/MediaObjects/41375_2014_Article_BFleu2013202_Fig1_HTML.jpg)
Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors | Leukemia
![Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling | Science Translational Medicine Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling | Science Translational Medicine](https://www.science.org/cms/asset/e5b5f6e5-e756-45eb-b0ec-64ac61505457/7-298ra119-f1.gif)
Tyrosine kinase inhibitor–induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling | Science Translational Medicine
![Novel copper complex CTB regulates methionine cycle induced TERT hypomethylation to promote HCC cells senescence via mitochondrial SLC25A26 | Cell Death & Disease Novel copper complex CTB regulates methionine cycle induced TERT hypomethylation to promote HCC cells senescence via mitochondrial SLC25A26 | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-03048-x/MediaObjects/41419_2020_3048_Fig5_HTML.png)
Novel copper complex CTB regulates methionine cycle induced TERT hypomethylation to promote HCC cells senescence via mitochondrial SLC25A26 | Cell Death & Disease
![Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics | Science Signaling Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics | Science Signaling](https://www.science.org/cms/10.1126/scisignal.abc7405/asset/90cd7e64-b6d9-4c5d-a7cc-215437da1e4c/assets/graphic/abc7405-f1.jpeg)
Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics | Science Signaling
![c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia | SpringerLink c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10495-022-01756-7/MediaObjects/10495_2022_1756_Fig7_HTML.png)
c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia | SpringerLink
![Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia | Science Advances Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia | Science Advances](https://www.science.org/cms/asset/7ca089cc-5eff-4666-90d5-2afb4b8612b2/abd6280-f1.gif)
Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia | Science Advances
![Cancers | Free Full-Text | Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism | HTML Cancers | Free Full-Text | Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism | HTML](https://www.mdpi.com/cancers/cancers-14-01446/article_deploy/html/images/cancers-14-01446-g005.png)
Cancers | Free Full-Text | Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism | HTML
![Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy | Nature Communications Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-26282-z/MediaObjects/41467_2021_26282_Fig1_HTML.png)
Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy | Nature Communications
![Nuclear NAD+ homeostasis governed by NMNAT1 prevents apoptosis of acute myeloid leukemia stem cells | Science Advances Nuclear NAD+ homeostasis governed by NMNAT1 prevents apoptosis of acute myeloid leukemia stem cells | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf3895/asset/984d68e3-8e4b-4ebc-a7de-50021915ade1/assets/graphic/abf3895-f1.jpeg)
Nuclear NAD+ homeostasis governed by NMNAT1 prevents apoptosis of acute myeloid leukemia stem cells | Science Advances
![Cancers | Free Full-Text | Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course | HTML Cancers | Free Full-Text | Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course | HTML](https://www.mdpi.com/cancers/cancers-13-06122/article_deploy/html/images/cancers-13-06122-g002.png)
Cancers | Free Full-Text | Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course | HTML
![Deciphering the molecular mechanism of FLT3 resistance mutations - Georgoulia - 2020 - The FEBS Journal - Wiley Online Library Deciphering the molecular mechanism of FLT3 resistance mutations - Georgoulia - 2020 - The FEBS Journal - Wiley Online Library](https://febs.onlinelibrary.wiley.com/cms/asset/9f41ebe0-4fa8-4ec4-9cf4-f48792365d38/febs15209-fig-0001-m.jpg)
Deciphering the molecular mechanism of FLT3 resistance mutations - Georgoulia - 2020 - The FEBS Journal - Wiley Online Library
![JCM | Free Full-Text | Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes | HTML JCM | Free Full-Text | Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes | HTML](https://www.mdpi.com/jcm/jcm-11-02378/article_deploy/html/images/jcm-11-02378-g001.png)
JCM | Free Full-Text | Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes | HTML
![Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia | Cell Death & Disease Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-022-05357-9/MediaObjects/41419_2022_5357_Fig1_HTML.png)
Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia | Cell Death & Disease
DNA Origami–Anthraquinone Hybrid Nanostructures for In Vivo Quantitative Monitoring of the Progression of Tumor Hypoxia Affected by Chemotherapy | ACS Applied Materials & Interfaces
![Frontiers | Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer Frontiers | Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer](https://www.frontiersin.org/files/Articles/871259/fphar-13-871259-HTML/image_m/fphar-13-871259-g004.jpg)
Frontiers | Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer
![Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy | Cell Death & Differentiation Reducing FASN expression sensitizes acute myeloid leukemia cells to differentiation therapy | Cell Death & Differentiation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41418-021-00768-1/MediaObjects/41418_2021_768_Fig1_HTML.png)